1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63C63F6260A5B28BB85257B1600532E28
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/3C63F6260A5B28BB85257B1600532E28!OpenDocument
18
19OpenDocument
203.227.3.146
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales Leadership Sales Training

Pharmaceutical Sales Training Excellence: Technology, Trends, and Best Practices that Drive Effectiveness

ID: 5240


Features:

21 Info Graphics

9 Data Graphics

145+ Metrics

16 Narratives

12 Best Practices


Pages/Slides: 38


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Pharmaceutical Sales Training Excellence: Technology, Trends, and Best Practices that Drive Effectiveness"

STUDY OVERVIEW

The curriculum and learning culture surrounding pharmaceutical Sales Training plays an important role in developing competent and effective Sales teams. Companies are looking to the changing technological landscape to enhance their efficiency and internal systems. As a result, savvy training leaders are keeping an eye on the horizon to identify and prepare for adoption of emerging technologies that may prove appropriate for their training programs.

This Best Practices, LLC study delivers performance benchmarks on emerging and existing technologies, mobile training, future trends and success drivers of leading Sales Training organizations across the pharmaceutical industry. The research also includes best practices for building an effective Sales Training program in today’s market and explores Sales Training’s Relationship with IT. Sales and Training leaders can use this study to evaluate and improve the manner in which they utilize popular innovations such as e-learning portals, virtual classrooms and LMS.


KEY TOPICS

  • Universe of Learning: Key Demographics of Participating Companies
  • Technology Issues & Applications
  • Trends in Pharmaceutical Sales Training
  • Best Practices of the Benchmark Class

SAMPLE KEY METRICS
  • New/ Innovative Technologies Companies are Currently Using or Planning to Deploy Within the Next Year to Deliver Sales Training
  • Effectiveness of Different Technologies In Delivering or Pushing Out Training
  • Effectiveness of Different Technologies as a Pull-Through Training Tool
  • Percentage of Core Training Delivered via the iPad and/or Other Similar Mobile Devices
  • Applications Developed Internally for Sales Training
  • Level of Attention from the Sales Training Organization Expected for Different Issues over the Next 12 Months
  • Best Practices for Building an Effective Sales Training Program in Today’s Market
SAMPLE KEY FINDING
  • Sales Training’s Relationship with IT Varies Widely: Across the benchmark class, companies have a wide spectrum of different relationships with their Information Technology partners. While some compete with other departments for attention, others have IT support inside the Sales Training function. Still others work primarily with vendors to deploy initiatives while partnering with IT for oversight.
METHODOLOGY

Best Practices, LLC engaged 28 Sales Training leaders from 25 pharmaceutical companies through a benchmarking survey instrument. In addition, research analysts conducted deep-dive executive interviews with 6 selected respondents to collect qualitative data and insights.

Industries Profiled:
Pharmaceutical; Medical Device; Manufacturing; Biotech; Consumer Products; Diagnostic; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Actavis; Arbor Pharmaceuticals; Astellas; AstraZeneca; Baxter Healthcare; Bayer; Biogen Idec; Celgene; Eli Lilly; EMD Serono; Genentech; Grifols; Janssen; Janssen Biotech; Johnson & Johnson Medical; Lundbeck; Novartis; Otsuka; Pfizer; Sanofi; Sanofi Oncology; Shire; Teva Pharmaceuticals; UCB; Valeant Canada

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.